| 08:50-09:00 |
Opening remarks |
대한치매학회회장 |
| |
Update on dementia |
좌장: 이애영 (충남의대) |
| 09:00-09:20 |
Genetics Update |
박영호 (서울의대) |
| 09:20-09:40 |
Microbiome Update |
이건호 (조선대학교) |
|
Upcoming AD drugs based on amyloid based monoclonal antibodies |
좌장: 이재홍 (울산의대)
정지향 (이화의대) |
| 09:40-10:05 |
The Gantenerumab Global Development Program for Alzheimer's Disease |
Scott Schobel (Roche) |
| 10:05-10:30 |
Clinical, Biomarker, and Safety Update from BAN2401-G000-201, the Lecanemab Phase 2 Proof of Concept Study and Open Label Extension |
Chad Swanson (Eisai) |
| 10:30-10:55 |
Future for the development of Alzheimer’s disease modifiers from clinical trial results of donanemab |
Ena Oru (Lilly) |
| 10:55-11:20 |
Coffee Break |
|
Plenary session I |
좌장: 박건우 (고려의대) |
| 11:20-12:00 |
Can we prevent aging? |
한설희 (건국의대) |
|
Plenary session II |
좌장: 양동원 (가톨릭의대) |
| 12:00-12:40 |
Alzheimer’s disease biomarkers: Towards a new era in the diagnosis and treatment of AD |
Gill Rabinovici (UCSF) |
| 12:40-13:00 |
총회 |
| 13:00-14:20 |
Lunch 및 Poster session |
| 14:20-15:20 |
Pannel discussion for Current Issues : Aducanumab! Is this new hope for Alzhiemer's ? |
Moderater: 박기형 (가천의대) |
|
Pannels: 이재홍, 양동원, 김상윤, 이애영 |
| 15:20-15:30 |
Coffee Break |
| |
Room A |
Room B |
| |
Recent R&D Achievements in Korea: KDRC supported projects |
좌장: 묵인희 (치매극복연구개발사업단)
박선아 (아주의대) |
A.I & Big data platform in Dementia |
좌장: 윤영철 (중앙의대)
정산 (한림의대) |
| 15:30-15:50 |
Development of tau-targeted therapeutic strategy for dementia |
김윤경 (KIST) |
Clinical application of A.I. in Dementia |
서상원 (성균관의대) |
| 15:50-16:10 |
Nanobiosensor technology for serological biomarker detection of neurodegenerative disease |
황교선 (경희의대) |
A.I in Neuroimaging of AD |
정용 (KAIST) |
| 16:10-16:30 |
Genetic factors of Alzheimer's disease in the Korean population |
김희진 (성균관의대) |
Dementia big data platforms in the UK, Europe and Korea |
김치헌 (한림의대) |
| 16:30-16:40 |
Coffee Break |
|
Blood biomarker for AD, now and future |
좌장: 김병채 (전남의대)
문소영 (아주의대) |
Digital Therapeutics (디지탈치료제) |
좌장: 최성혜 (인하의대)
나해리 (보바스기념병원) |
| 16:40-17:00 |
Clinical usefulness and need of blood biomarkers in the diagnosis and follow-up of AD |
고성호 (한양의대) |
디지털 치료제의 현안과 미래 |
한영민 주무관 (식품의약품안전처) |
| 17:00-17:20 |
Introduction of Currently Available Blood Based Biomarker of AD |
장재원 (강원의대) |
디지털 치료제 개발과 향후 전망 |
김진우 대표 (㈜하이) |
| 17:20-17:40 |
Clinical application of AD blood biomarker: expectations & concerns |
심용수 (가톨릭의대) |
디지털헬스케어/디지털치료제는 어떻게 비지니스가 되는가 |
김치원 상무 (카카오벤처스) |
| 17:40-17:50 |
Closing remarks 및 시상식 |
